期刊文献+

一种潜在5-HT_(1A)脑受体显像剂^(99)Tc^m-Bicine/HYNIC-MPP2的制备及其生物性能 被引量:2

Preparation and Bio-Evaluation of ^(99)Tc^m-Bicine/HYNIC-MPP2 as a Novel Agent for 5-HT_(1A) Receptor Imaging
暂未订购
导出
摘要 优化合成了含有1-(2-甲氧基苯基)哌嗪(MPP)结构的配体2-(4-(2-甲氧基苯基)哌嗪基)乙胺-6-叔丁基氧羰基肼基吡啶-3-甲酸(HYNIC-MPP2)。在室温下以N,N-二(2-羟基乙基)氨基乙酸(Bicine)为共配体制备得到配合物99Tcm-Bicine/HYNIC-MPP2,其放射化学纯度大于95%,并且在6 h内保持稳定。脂水分配系数和电泳实验结果表明,该放射性标记配合物是水溶性和电中性的。正常小鼠体内生物分布实验结果表明,99Tcm-Bicine/HYNIC-MPP2有一定的脑摄取(注射后2 min时为0.31%ID/g)。脑区域分布及抑制实验显示,该配合物在5-HT1A受体含量丰富的海马组织有较高摄取(注射后2 min时为1.00%ID/g),而在受体含量低的小脑组织中摄取也低(注射后2 min时为0.63%ID/g)。抑制后,海马摄取降低较多(注射后2 min时为0.42%ID/g),而小脑摄取则无明显变化。抑制前后海马/小脑比值分别为1.59和0.89。由此可见该标记配合物与5-HT1A受体具有一定特异性结合,是一种新的潜在5-HT1A受体显像剂。 The goal of this study is to develop a new ^99Tc^m-complex as a potential 5-HT1A receptor imaging agent. Ligand HYNIC-MPP2, containing the MPP moiety was synthesized and labeled with technetium-99m. The ^99Tc^m-Bicine/HYNIC-MPP2 complex was prepared in high yield (〉95% by TLC) with N, N-bis(2-hydroxyethyl)glycine (Bicine) as coligand at room temperature (RT) and it remained stable over 6 h at RT. ^99Tc^m-Bicine/HYNIC-MPP2 complex is neutral and hydrophilic, that were conformed by paper electrophoresis and octanol/water partition coefficient, respectively. In vivo biodistribution of ^99Tc^m-Bicine/HYNIC-MPP2 was investigated in normal mice. The result shows that this complex has moderate brain uptake (0.31%ID/g at 2 min post-injection(p, i. )). The regional brain distribution and blocking studies show that its hippocampus uptake of ^99Tc^m-Bicine/HYNiC-MPP2 is the highest (1.00 %ID/ g at 2 min p. i. ), while the cerebellum uptake is only 0.63%ID/g at 2 min p. i.. This is agreed with the distribution of 5-HT1A receptor in the brain. After blocking with 8-OH-DPAT, the uptake of hippocampus is decreased obviously (0.42%ID/g), while the eerebellar uptake has no significant difference. The hippocampus/cerebellum uptake ratio is decreased from 1.59 to 0.89 after blocking. This result shows that ^99Tc^m-Bicine/HYNIC-MPP2 has specific binding to the 5-HT1A receptor and it can be developed as a potential 5-HT1A receptor imaging agent in the future.
出处 《核化学与放射化学》 CAS CSCD 北大核心 2009年第4期206-211,共6页 Journal of Nuclear and Radiochemistry
基金 国家自然科学基金资助项目(No.20401004)
  • 相关文献

参考文献20

  • 1Gross C, Zhuang X, Stark K, et al. SerotoninlA Receptor Acts During Development to Establish Normal Anxiety-Like Behaviour in the Adult[J]. Nature, 2002, 416 (6 879): 396-400.
  • 2Fletcher A, Bill D, Cliffe I, et al. A Pharmaeologi-cal Profile of WAY-100635, a Potent and Selective 5-HT1A Receptor Antagonist[J]. Br J Pharmacol, 1994, 112: 91.
  • 3Le Bars D, Lemaire C, Ginovart N, et al. High- Yield Radiosynthesis and Preliminary in Vivo Evaluation of p-[18F]MPPF, a Fluoro Analog of WAY-.100635[J]. Nucl Mect Biol, 1998, 25 (4): 343-350.
  • 4Garcia R, Xavier C, Paulo A, et al. Synthesis and Biological Evaluation of S-[11C]Methylated Mercaptoimidazole Piperazinyl Derivatives as Potential Ra- dioligands for Imaging 5-HT1A Receptors by Positron Emission Tomography (PET) [J]. J Label Compd Radiopharm, 2005, 48 (4): 301-315.
  • 5Sanabria-BohorquezSM, BiverF, DamhautP, et al. Quantification of 5-HT1A Receptors in Human Brain Using p-MPPF Kinetic Modelling and PET[J]. EurJ Nucl Med, 2002, 29: 76-81.
  • 6Costes N, Merlet I, Ostrowsky K, et al. A 18FMPPF PET Normative Database of 5-HT1A Receplor Binding in Men and Women Over Aging[J]. J Nucl Med, 2005, 46 (12): 1 980-1 989.
  • 7Vandecapelle M, Dumont F, Vos F D, et al. Synlhesis and Preliminary in Vivo Evaluation of 4-[18 F] Fluoro-N- { 2-[ 4-( 6-Trifluoromethylpyridin-2-yl ) Piperazin-l-yl]Ethyl}Benzamide, a Potential PET Radioligand for the 5-HT1A Receptor[J]. J Label Compd Radiopharm, 2004, 47 (9): 531-542.
  • 8Tipre D N, Zoghbi S S, Liow J-S, et al. PET Imaging of Brain 5-HTIA Receptors in Rat in Vivo With 18 F FCWAY and Improvement by Successful Inhibi tion of Radioligand Defluorination With Miconazole[J]. J Nucl Med, 2006, 47 (2): 345-353.
  • 9IAEA. Development of 99mTc Agents for Imaging Central Neural System Receptors: Technical Reports Series, No. 426 [R]. Vienna: International Atomic Energy Agency, 2004.
  • 10刘飞,贺佑丰,罗志福,刘英妹.^(99)Tc^m标记5-HT_(1A)脑受体显像剂的研制及其生物分布[J].同位素,2001,14(3):129-135. 被引量:4

二级参考文献34

  • 1楚进锋,李彬,孔德靖,王学斌,张俊波,王金城,米宏志,赵建冬.[^(99)mTcN(PNP5)(NOEt)]^+新型心肌灌注显像剂研究[J].高等学校化学学报,2005,26(6):1014-1017. 被引量:7
  • 2Garcia R, Xavier C, Paulo A, et al. Synthesis and biological evaluation of S-[^11C] methylated mercaptoi-midazole piperazinyl derivatives as potential radioligands for imaging 5-HT1A receptors by positron emission tomography (PET)[J]. J Label Compd Radiopharm,2005, 48(4) :301
  • 3Sanabria-Bohorquez S M, Biver F, Damhaut P, et al.Quantification of 5-HT1A receptors in human brain using p-MPPF kinetic modelling and PET[J]. Eur J Nucl Med,2002, 29:76
  • 4Costes N, Merlet I, Ostrowsky K, et al. A 18 F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging[J]. J Nucl Med, 2005, 46(12) : 1980
  • 5Gross C, Zhuang X, Stark K, et al. Serotonin 1A receptor acts during development to establish normal anxiety-like behaviour in the adult[J]. Nature, 2002, 416(6879) :396
  • 6Pike V W, Halldin C, Wikstrom H, et al. Radioligands for the study of brain 5-HT1A receptors in vivo-development of some new analogues of way[J]. Nucl Med Biol, 2000, 27(5):449
  • 7Fletcher A, Bill D, Cliffe I, et al. A pharmacological profile of WAY-100635, a potent and selective 5-HT1A receptor antagonist [abstract ] [J ]. Br J Pharmacol,1994, 112:91
  • 8Le Bars D, Lemaire C, Ginovart N, et al. Highyield radiosynthesis and preliminary in vivo evaluation of p-[^18F]MPPF, a fluoro analog of WAY-100635[J]. Nucl Med Biol, 1998, 25(4):343
  • 9Vandecapelle M, Dumont F, Vos F D, et al. Synthesis and preliminary in vivo evaluation of 4-[^18 F]fluoro-N-{ 2- 4- ( 6-trifluoromethylpyridin-2-yl ) piperazin-l-yl ] ethyl }benzamide, a potential PET radioligand for the 5-HT1A receptor [J]. J Label Compd Radiopharm, 2004, 47(9) :531
  • 10Tipre D N, Zoghbi SS, LiowJ S, et al. PET imaging of brain 5-HT1A receptors in rat in vivo with 18 F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole [J]. J Nucl Med, 2006,47(2):345

共引文献5

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部